Global Leukapheresis Products Market Size, Share, Forecast Report, 2020-2027

Market Scenario:

Global leukapheresis products market is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 19.2 million in 2017 and is projected to grow at a CAGR of 7.7% over the forecast period.

Leukapheresis is a procedure of removing abnormal white blood cells (WBCs) from the blood. Leukapheresis can be used as a treatment for certain types of leukemia or as the first step of chimeric antigen receptor (CAR) T-cell therapy. The growing number of blood donations, increasing prevalence of leukaemia, and demand for leukapheresis products in clinical research are some factors that are anticipated to propel the growth of the market. According to the Facts and Figures 2017-2018 by the Leukemia and Lymphoma Society, an estimated 1,345,123 people in the US are living with or in remission from leukemia, lymphoma or myeloma. On the other hand, the high cost of therapeutic leukapheresis, dearth of skilled professionals, and stringent donor recruitment criteria may hinder the market growth over the forecast period.

Segmentation:

The global leukapheresis products market has been segmented into type, application, and end user. On the basis of type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column & cell separators, and leukoreduction filters.

The market, on the basis of application, has been segmented into research applications and therapeutic applications.

On the basis of end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.
Key players:

Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, StemExpress and others are some of the key players in the global leukapheresis products market.

Global Leukapheresis Products Market, by Type

  • Leukapheresis Devices
  • Apheresis Devices
  • Leukapheresis Columns & Cell Separators
  • Leukoreduction Filters
  • Leukapheresis Disposables

Global Leukapheresis Products Market, by Application

  • Research Applications
  • Therapeutic Applications

Global Leukapheresis Products Market, by End User

  • Blood Component Providers and Blood Centers
  • Hospitals and Transfusion Centers
  • Others

Global Leukapheresis Products Market, by Region

  • Americas
    • North America
      • US
      • Canada
    • South America
  • Europe
    • Western Europe
      • Germany
      • France
      • Italy
      • Spain
      • UK
      • Rest of Western Europe
    • Eastern Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • The Middle East & Africa
    • Middle East
    • Africa

Global Leukapheresis Products Market, by Key Players

  • Haemonetics
  • Terumo BCT
  • Asahi Kasei Medical
  • STEMCELL Technologies
  • Macopharma
  • Caltag Medsystem
  • ZENBIO
  • Fresenius Kabi
  • PPA Research Group
  • StemExpress
  • HemaCare Corporation
  • ALLCells, LLC
  • Others

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-img Cross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers